Cabot (NYSE:CBT) Stock Rating Upgraded by ValuEngine

Cabot (NYSE:CBT) was upgraded by ValuEngine from a “sell” rating to a “hold” rating in a report released on Tuesday, ValuEngine reports.

A number of other equities research analysts also recently issued reports on the stock. Robert W. Baird downgraded shares of Cabot from an “outperform” rating to a “neutral” rating and set a $45.00 price target on the stock. in a report on Wednesday, October 16th. JPMorgan Chase & Co. downgraded shares of Cabot from an “overweight” rating to a “neutral” rating and increased their price target for the stock from $40.00 to $45.00 in a report on Wednesday, November 6th. They noted that the move was a valuation call. Loop Capital downgraded shares of Cabot from a “buy” rating to a “hold” rating and lowered their price target for the stock from $69.00 to $41.00 in a report on Monday, August 5th. Zacks Investment Research downgraded shares of Cabot from a “hold” rating to a “sell” rating and set a $47.00 price target on the stock. in a report on Friday, October 25th. Finally, Northcoast Research set a $45.00 price target on shares of Cabot and gave the stock a “buy” rating in a report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company’s stock. Cabot has an average rating of “Hold” and an average price target of $44.67.

Shares of NYSE:CBT opened at $46.67 on Tuesday. The company has a quick ratio of 1.24, a current ratio of 2.02 and a debt-to-equity ratio of 0.90. The firm has a market capitalization of $2.68 billion, a PE ratio of 11.94, a P/E/G ratio of 1.23 and a beta of 1.56. Cabot has a twelve month low of $37.11 and a twelve month high of $50.90. The company has a 50-day moving average price of $46.70 and a two-hundred day moving average price of $44.25.

Cabot (NYSE:CBT) last issued its earnings results on Monday, November 4th. The specialty chemicals company reported $1.05 earnings per share for the quarter, missing analysts’ consensus estimates of $1.11 by ($0.06). The business had revenue of $827.00 million for the quarter, compared to the consensus estimate of $849.44 million. Cabot had a return on equity of 19.06% and a net margin of 4.70%. Cabot’s revenue for the quarter was down 2.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.00 EPS. Analysts anticipate that Cabot will post 3.82 earnings per share for the current fiscal year.

Several institutional investors have recently made changes to their positions in the company. LSV Asset Management raised its stake in Cabot by 0.9% in the second quarter. LSV Asset Management now owns 2,793,804 shares of the specialty chemicals company’s stock valued at $133,292,000 after purchasing an additional 26,137 shares in the last quarter. Earnest Partners LLC raised its stake in Cabot by 57.9% in the second quarter. Earnest Partners LLC now owns 2,382,366 shares of the specialty chemicals company’s stock valued at $113,663,000 after purchasing an additional 873,528 shares in the last quarter. Bank of America Corp DE raised its stake in Cabot by 17.6% in the second quarter. Bank of America Corp DE now owns 1,196,424 shares of the specialty chemicals company’s stock valued at $57,082,000 after purchasing an additional 178,945 shares in the last quarter. Deprince Race & Zollo Inc. raised its stake in Cabot by 17.4% in the second quarter. Deprince Race & Zollo Inc. now owns 839,165 shares of the specialty chemicals company’s stock valued at $40,037,000 after purchasing an additional 124,654 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in Cabot by 2.7% in the second quarter. Charles Schwab Investment Management Inc. now owns 473,237 shares of the specialty chemicals company’s stock valued at $22,579,000 after purchasing an additional 12,461 shares in the last quarter. 84.40% of the stock is currently owned by hedge funds and other institutional investors.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers rubber grade carbon blacks used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and compounds of carbon black and rubber.

Recommended Story: Return on Investment (ROI) Defined, Explained

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.